VGH Infection Control Project & MRSAid™ Featured on Canadian National News!

A few days ago, we announced an innovative partnership with one of Canada`s largest hospitals, Vancouver General Hospital (VGH). We are very excited to have this partnership featured on Global News.

Pathogenic bacteria such as Staphylococcus aureus and MRSA can significantly increase the risk of a patient developing serious infections after surgery. MRSAidTM is a non-antibiotic therapy designed to eliminate bacteria in the noses of patients during high infection risk times. As part of our partnership with VGH, MRSAidTM will be used on patients undergoing cardiac, spinal, breast reconstruction, thoracic, neurological, and orthopaedic surgeries. We are very excited to be working with the leaders in infection control at VGH. For more information on MRSAidTM, please visit Also, please connect with us on TwitterFacebook, we`ll be happy to respond to any comments and questions.

Related Posts Plugin for WordPress, Blogger...

Leave a Reply

Staypressed theme by Themocracy